CYTOKINETICS INC

CYTK · Nasdaq · SIC 2834: Pharmaceutical Preparations
198
SEC Filings

Business Summary

Overview We are a biopharmaceutical company focused on discovering, developing and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. We have discovered and are developing muscle-directed investigational medicines that may potentially improve the healthspan of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function. Our first commercial p...

Next Earnings

Q2 FY2026 — expected 2026-09-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCYTKdiscussed_in_filing Cybersecurity
topic_mentionCYTKdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076495EDGAR73K words
2025-02-272024-12-310000950170-25-029206EDGAR—
2024-02-282023-12-310000950170-24-022256EDGAR—
2023-03-012022-12-310000950170-23-005515EDGAR—
2022-02-252021-12-310001564590-22-007218EDGAR—
2021-02-262020-12-310001564590-21-009467EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-267059EDGAR49K words
2025-08-072025-06-300000950170-25-105108EDGAR—
2025-05-062025-03-310000950170-25-064529EDGAR—
2024-11-072024-09-300000950170-24-123283EDGAR—
2024-08-092024-06-300000950170-24-094743EDGAR—
2024-05-102024-03-310000950170-24-057805EDGAR—
2023-11-032023-09-300000950170-23-058914EDGAR—
2023-08-032023-06-300000950170-23-037995EDGAR—
2023-05-052023-03-310000950170-23-018305EDGAR—
2022-11-042022-09-300000950170-22-022207EDGAR—
2022-08-052022-06-300000950170-22-015117EDGAR—
2022-05-062022-03-310000950170-22-008125EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-240001193125-26-067012EDGAR4K words
2026-02-170001193125-26-053049EDGAR—
2025-12-190001193125-25-326778EDGAR—
2025-12-120001193125-25-316904EDGAR—
2025-11-140001193125-25-282889EDGAR—
2025-11-050001193125-25-266842EDGAR—
2025-09-220001193125-25-209437EDGAR—
2025-09-160001193125-25-204991EDGAR—
2025-09-030000950170-25-112570EDGAR—
2025-09-020000950170-25-112564EDGAR—

198 total filings indexed. 170 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001061983
TickerCYTK
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b0896972cc8ce3a23dc44985c393d05068ea9ba35db78f67e9748549c223490f
parent: 78a339290f644d9ce7119243bf4567c28f5ab735bd62dd6306d2fc06c8a3d7f8
content hash: e0f8c30956bdf16cbc6d6c6a13d1b9a8c7b7c77a80ed6a91db1224dd18a89bc9
signed: 2026-04-13T04:44:35.977Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf